 |
Executive Officers
D. Keith Grossman
President, Chief Executive
Officer, and Director
Lawrence Cohen
President,
International Technidyne
Corporation
Jeffrey W. Nelson
President,
Cardiovascular Division
Board of Directors
J. Donald Hill, M.D.
Chairman of the Board,
Thoratec Corporation
Clinical Professor,
University of California at
San Francisco
San Francisco, California
Howard E. Chase
President,
The Hollandbrook Group, LLC
Somerset, New Jersey
J. Daniel Cole
General Partner,
Spray Venture Fund
Boston, Massachusetts
Neil Dimick
Executive Vice President
and Chief Financial Officer,
AmerisourceBergen Corporation
(Retired)
Laguna Hills, California
|
|
D. Keith Grossman
President, Chief Executive
Officer, and Director
William M. Hitchcock
President,
Avalon Financial, Inc.
Houston, Texas
George W. Holbrook, Jr.
Managing Partner,
Bradley Resources Company
Southport, Connecticut
Daniel M. Mulvena
Founder and Owner,
Commodore Associates
Marblehead, Massachusetts
General Counsel
David A. Lehman
Vice President,
General Counsel,
and Secretary
Independent Registered
Public Accounting Firm
Deloitte & Touche LLP
San Francisco, California
Stock Transfer Agent
Computershare Investor Services
350 Indiana Street,
Suite 800
Golden, Colorado 80401
|
|
Additional Information
For more information,
please write to:
Corporate Secretary
Thoratec Corporation
6035 Stoneridge Drive
Pleasanton, California 94588
www.thoratec.com
Annual Meeting
The Company’s annual meeting of shareholders will be held May 25, 2005 at 9:00 a.m.
Trademarks
Thoratec, the Thoratec logo, Thoralon, TLC-II, HeartMate, and Vectra are registered trademarks, and Heart Hope and IVAD are trademarks of Thoratec Corporation.
HEMOCHRON, ProTime, Surgicutt, Tenderlett, tenderfoot and IRMA are registered trademarks, and TRUpoint and Hgb Pro are trademarks of International Technidyne Corporation.
|
